Filing Details
- Accession Number:
- 0001127602-10-007474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-04 12:00:00
- Reporting Period:
- 2010-03-03
- Filing Date:
- 2010-03-04
- Accepted Time:
- 2010-03-04 14:46:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224653 | Jr F James Winschel | Parexel International Corporation 195 West Street Waltham MA 02451 | Senior Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-03 | 25,000 | $4.03 | 241,885 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-03 | 15,600 | $21.55 | 226,285 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-03-03 | 25,000 | $0.00 | 25,000 | $4.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2010-10-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,444 | Indirect | Owned By Sons. |
Footnotes
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $21.50-$21.61. The price reported in this column reflects the weighted average sales price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares sold at each price.
- Includes 799 shares of common stock acquired pursuant to the Issuer's 2000 Employee Stock Purchase Plan.
- The reporting person disclaims beneficial ownership of all securities held by his sons, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.
- Currently exercisable.
Billionaire Hedge Funds
